Compared to superficial spreading subtypes of melanoma, lesions that were lentigo maligna melanoma (OR = 0.16, 95% CI 0.04–0.67) were at decreased odds of having an NRAS mutation (p = 0.02). The gene discussed is NRAS; the disease is melanoma.